evenfolio

Chemicals · NSE: SUMICHEM

Sumitomo Chemical India

Price as of 12 Nov 2026
356.65+2.21%

Q2 FY27 earnings call · Guided by management

Call held 27 Oct 2026 · Read the filing on NSEFiling

20​%EBITDA margin objective (equal to or more than)Mittal · p. 7
₹150​CrCapex · DahejMittal · p. 8
1–2​products/yearNew product introductions per year · next 3 to 5 yearsMittal · p. 9
9–10​%Innovation turnover indexRamachandran · Q&A · p. 12
M.Cap
₹17,802Cr
P/E
31.9×
1Y return
−25.02%
From 52W high
−37.6%

Highlights are read by AI from the company's filing and can contain mistakes. Check the source page linked to each line.

Share price

Results Q2 FY27, as filed · consolidated · ₹ Cr

Q2 FY27Q2 FY26YoYQ1 FY27QoQ
Revenue907930-2.4%1,063-14.7%
EBITDA186218-14.8%233-20.4%
EBITDA margin20.5%23.4%-298 bps21.9%-147 bps
One-off items———27—
PBTProfit before tax210238-11.6%288-27.1%
Net profit157178-11.5%215-26.8%
EPS (₹)3.143.56-11.8%4.30-27.0%

From the company's own results filing on NSE. Net profit is the owners' share. Growth and the dotted lines are worked out from the filed figures.

Guidance

EBITDA margin · long term20%Objective to keep EBITDA margin equal to or above 20%
CapexRs 150 CrInvesting about Rs 150 crore in greenfield Dahej site; plans on track
Capex3-4 productsTarapur capex totals Rs 20 crore, adding 3 to 4 products
Capex · long term5-10 yearsDahej to be developed with more projects over next 5 to 10 years
Capex · long termRs 50-70 CrMaintenance and debottlenecking capex about Rs 50 crore to Rs 70 crore

H2 goal is to grow over last year's sales while protecting profitability

Suresh Ramachandran · Managing Director · p. 6
“Our goal for H2 is to grow over last year's sales where the market allows while protecting profitability.”

H2 margins expected in the normal historical range

Kunal Mittal · Executive Vice President · Q&A · p. 17
“But in H2 at this point of time based on all the information available, our margins are expected to be in the normal kind of a range as per the historical levels.”

Stable performance expected in H2, including margins

Kunal Mittal · Executive Vice President · Q&A · p. 16
“So as a combination of that, we are expecting a stable kind of a performance and including on the margin front.”

More figures from the call

Dahej · Capex
0–5​yearsPayback period
“it is a very healthy turnover ratio and the payback period is less than 5 years and the margin profile should be in line with the company level margins.”
Kunal Mittal · Executive Vice President · Q&Ap. 15
Tarapur · Capex
₹10​CrCapex per project
“During last 12 months, we have announced two capex at Tarapur site, both of these are INR10 crores each.”
Kunal Mittal · Executive Vice Presidentp. 8
Company · One-offs
₹26.9​CrExceptional income · Q1 FY27
“Q1 FY '27 included exceptional income of INR26.9 crores. This was the insurance claim received from business interruption caused by the fire at our Bhavnagar plant in FY '23.”
Anil Nawal · Chief Financial Officerp. 9
Company · Acquisitions and new business
4–5​productsParent blockbuster products
“But like this, there are 4 or 5 blockbuster products which have been just launched or expected to be launched by our parent company soon and each of these require multiple I think intermediates and the final TG product.”
Kunal Mittal · Executive Vice President · Q&Ap. 16
Company · Segments
4–5​yearsTime to introduce new products
“These products will take at least 4, 5 years of introduction.”
Suresh Ramachandran · Managing Director · Q&Ap. 17

In short

  1. 01Q2 FY27 revenue was Rs 907 crore, down 2%; H1 revenue Rs 1,971 crore, down 1%.
  2. 02Q2 gross margin 40.7% and EBITDA margin 20.5%, hit by higher-cost inventory; company targets EBITDA margin of 20% or more.
  3. 03Management expects H2 to stay challenging but aims to grow over last year's sales, with margins in the historical range.
  4. 04Inventory days rose to 115 from 95; management expects inventory to normalise through H2.
  5. 05Dahej Rs 150 crore herbicide-intermediate project on track, commercialisation expected Q2 FY 2028-29; Tarapur Rs 20 crore capex adds 3 to 4 products.
  6. 06Exports fell 23% in Q2 on parent-company overstocking; Japan exports almost halved, seen as a this-year issue.
  7. 07Cash and liquid investments about Rs 2,523 crore; no plan now to return cash to shareholders.
  8. 08Semiconductor chemicals MOU is at parent level; the Indian entity's role is not yet defined.

Capex

Dahej: Rs 150 crore Dahej plant is only for one intermediate for one herbicide

Kunal Mittal · Executive Vice President · Q&A · p. 15
“So this is like one step in the overall development of Dahej site with a INR150 crores investment. This is only for one intermediate for one blockbuster herbicide.”

Dahej: Dahej commercialisation expected Q2 FY 2028-29 (July-October 2028)

Kunal Mittal · Executive Vice President · Q&A · p. 22
“that is expected to be commercialized in Q2 financial year 2028-'29. So more specifically, the calendar year would be 2028 sometime, say, July to October kind of a situation.”

Tarapur: Tarapur part one due this year, part two by end of FY 2027-28

Kunal Mittal · Executive Vice President · p. 8
“one part of this capex, first part is expected to be completed within this current financial year and the second part is expected to be completed by end of the next financial year 2027 -28.”

Tarapur: Tarapur expansion is for the domestic market, not exports

Kunal Mittal · Executive Vice President · p. 8
“Some of this growth will also be in domestic market because some of this expansion, especially in the Tarapur site, is for domestic Indian market and not particularly focused on exports opportunities.”

Evaluating more capex projects for parent company's global needs

Kunal Mittal · Executive Vice President · p. 9
“We are also evaluating few more additional capex projects for our parent company’s global needs and we will keep updating you as and when any project is approved by our parent company and our Board.”

Capacity

INDIFLIN: No capex approved for INDIFLIN capacity for global needs

Kunal Mittal · Executive Vice President · Q&A · p. 13
“So currently we have not approved any capex for setting up the capacity for INDIFLIN for the global requirement point of view.”

INDIFLIN: INDIFLIN manufacturing for India by end of this year; no firm export plan

Kunal Mittal · Executive Vice President · Q&A · p. 13
“For the Indian quantities, we'll be manufacturing by end of this financial year. But there are no firm export plan of INDIFLIN from India which would happen as of now.”

Next year expects higher use of existing facilities and some volume increase

Kunal Mittal · Executive Vice President · Q&A · p. 21
“What is expected to come is higher utilization of the existing facilities and some increase in the volumes.”

Exports: Has capacity to meet export requirement, including for parent company

Suresh Ramachandran · Managing Director · Q&A · p. 18
“But however, our focus remains on export wherever we have registrations and of course our parent company, we continue to do that and we have the capacity to fulfill the requirement.”

Segments

specialty products: Key specialty brands grew about 22% in value over H1 of last year

Suresh Ramachandran · Managing Director · p. 5
“Together, these products grew about 22% in value over H1 of last year despite a very weak monsoon.”

Domestic: Q2 domestic revenue grew 2% to Rs 774 crore; H1 domestic stable at Rs 1,657 crore

Kunal Mittal · Executive Vice President · p. 7
“Q2 domestic revenues grew 2% to INR774 crores and H1 domestic revenue was broadly stable at INR1,657 crores.”

Domestic: Branded products about 79% of domestic revenue

Kunal Mittal · Executive Vice President · p. 7
“Branded products made about 79% of domestic revenue.”

Exports: Q2 exports fell 23% to Rs 127 crore on timing of Japan and South America shipments

Kunal Mittal · Executive Vice President · p. 7
“If we talk about exports, there was a decline of 23% in Q2 to INR127 crores mainly due to the timing of shipments to Japan and South America.”

Exports: H1 exports stable at Rs 300 crore; Africa, South America, Asia, Europe up 15-19%

Kunal Mittal · Executive Vice President · p. 7
“For H1, exports were stable at INR300 crores with Africa, South America, Asia and Europe; each growing by 15% to 19%.”

Demand

H1 FY27 called one of the most difficult first halves for the industry in over a decade

Suresh Ramachandran · Managing Director · p. 4
“H1 FY '27 was one of the most difficult first halves for the Indian agrochemical industry in over a decade. The main reason was the erratic and unpredictable monsoon.”

Monsoon season ended with a deficit of almost 13% of normal rainfall

Suresh Ramachandran · Managing Director · p. 4
“Overall, the season ended with a deficit of almost 13% of the normal rainfall.”

Delayed sowing and dry spells cut herbicide, insecticide and fungicide demand

Suresh Ramachandran · Managing Director · p. 4
“Delayed sowing and dry spells reduced herbicide consumption. In August and September, farmers skipped spray rounds, which lowered demand for insecticides and fungicides.”

H2 of the current year expected to remain challenging

Suresh Ramachandran · Managing Director · p. 5
“We expect H2 of the current financial year to remain challenging for three main reasons.”

Sales volumes fell by a high single-digit percentage on weak consumption

Kunal Mittal · Executive Vice President · p. 7
“Our sales volumes, however, fell by a high single-digit percentage due to lower consumption in the adverse weather conditions.”

Margins and costs

Input costs rose on war, rupee and freight; SCIL passed on increases largely

Suresh Ramachandran · Managing Director · p. 4
“The cost increased because of the Middle Eastern war, the technical prices went up, a weaker rupee depreciation and high packaging, solvent and freight costs added to the overall cost of inputs. Companies including SCIL passed on these increases to a large extent.”

Industry carried high-cost inventory into lower volumes and softer prices in Q2

Suresh Ramachandran · Managing Director · p. 4
“The industry, therefore, carried high cost inventory into the period of lower volume and softer prices in Q2.”

Q1 revenue helped by March-June price rises; Q2 selling prices kept largely stable

Kunal Mittal · Executive Vice President · p. 7
“In Q1, our revenues were supported by the price increases which we took between the months of March and June 2026. In Q2, we kept our selling prices largely stable.”

Q2 gross margin 40.7% (down 240 bps), EBITDA margin 20.5% (down 297 bps)

Kunal Mittal · Executive Vice President · p. 7
“As a result, our Q2 gross margin was 40.7%, which was down 240 basis point year-on-year and our EBITDA margin was 20.5%, which was down 297 basis points.”

H1 gross margin 39.9% vs 40.4%; EBITDA margin 21.3% vs 22%

Kunal Mittal · Executive Vice President · p. 7
“For HI financial year '27, gross margin was 39.9% compared with 40.4% last year and EBITDA margin was 21.3% compared with 22%.”

Debt and working capital

Cash and liquid investments about Rs 2,523 crore at 30 Sept 2026, up from Rs 2,113 crore

Kunal Mittal · Executive Vice President · p. 8
“Cash and cash equivalent and liquid investments were approximately INR2,523 crores as of 30th September 2026, up from INR2,113 crores in March 2026.”

Balance sheet remains essentially debt-free

Kunal Mittal · Executive Vice President · p. 8
“If we talk about our balance sheet and working capital, our balance sheet remains essentially debt-free.”

H1 net cash from operations Rs 447 crore vs Rs 435 crore

Kunal Mittal · Executive Vice President · p. 8
“Net cash from operations in H1 financial year '27 was INR447 crores compared with INR435 crores in H1 2026.”

Trade receivables Rs 887 crore, lower than Rs 903 crore a year ago

Kunal Mittal · Executive Vice President · p. 8
“Trade receivables at the end of September were INR887 crores, lower than INR903 crores a year ago.”

Net working capital 76 days in September 2026 vs 55 days a year earlier

Kunal Mittal · Executive Vice President · p. 8
“Overall, net working capital was 76 days as of September 2026 compared with 55 days in September 2025.”

Acquisitions and new business

biostimulants: Launched Topgrain, a patented grain-filling biostimulant; India first to launch it

Suresh Ramachandran · Managing Director · p. 5
“In the entire world, we are proud to announce that India is the first country to commercially launch this product anywhere in the world.”

insecticides: Launched Helibex insecticide to a limited extent from August

Suresh Ramachandran · Managing Director · p. 5
“The second product is Helibex, which is an insecticide launched to a limited extent starting from August to control key caterpillar pest.”

semiconductor chemicals: Parent signed semiconductor MOU with India's first fab developer

Kunal Mittal · Executive Vice President · Q&A · p. 10
“And recently MOU was signed between one of the leading semiconductor players in India, which is developing our first fabrication plant for semiconductors in India, which is expected to become operational in a very short- to medium-term period.”

semiconductor chemicals: Semiconductor chemicals not candidates to start immediately; localisation takes time

Kunal Mittal · Executive Vice President · Q&A · p. 11
“However, our products are not the candidates to start immediately. The localization plant is going to take some time.”

semiconductor chemicals: Indian entity part of semiconductor talks but no specific role defined

Kunal Mittal · Executive Vice President · Q&A · p. 11
“Sumitomo Chemical India is in some way part of those discussions, but nothing concrete, firm, structure or any kind of a specific role has been defined.”

Dividends and buybacks

No plan now to return cash to shareholders; prefers growth uses

Kunal Mittal · Executive Vice President · Q&A · p. 24
“So at this point of time, we don't believe that we should give up any kind of future growth and give this cash return to the shareholders.”

Use of cash is a decision for the Board

Suresh Ramachandran · Managing Director · Q&A · p. 15
“See, the utilization of cash is a different objective that calls for a larger discussion at the Board.”

Will put idea of returning unused cash to shareholders to the Board

Kunal Mittal · Executive Vice President · Q&A · p. 24
“But in the future, I think we take your point which you mentioned that if there is no usage of the cash, it should be returned to the shareholders. So we will put it to the Board and our Board will keep taking I think decision.”

Management

Suresh Ramachandran took charge as Managing Director on 1 September 2026

Suresh Ramachandran · Managing Director · p. 3
“This is my first earnings call since taking charge as Managing Director on 1st September of 2026 and I would like to begin with a few words on the transition.”

Former MD Chetan Shah appointed Non-Executive Director and Chairman of the Board

Suresh Ramachandran · Managing Director · p. 3
“Following shareholders' approval, he has been appointed as Non-Executive Non-Independent Director and has also been appointed as Chairman of the Board.”

Executive Director Sushil Marfatia completed his term on 31 August 2026

Suresh Ramachandran · Managing Director · p. 3
“Mr. Sushil Marfatia also completed his term as Executive Director on 31st August 2026.”

Anand Mohan Tiwari joined the Board as Independent Director

Suresh Ramachandran · Managing Director · p. 3
“We also welcome Mr. Anand Mohan Tiwari to the Board as Independent Director.”

Dr. Mukul Asher completed his term as Chairman and Independent Director on 31 August 2026

Suresh Ramachandran · Managing Director · p. 3
“Dr. Mukul Asher, who completed his term as Chairman and Independent Director on 31st August 2026”

Risks

El Nino expected to peak around December and last through February 2027

Suresh Ramachandran · Managing Director · p. 5
“The World Meteorological Organization expects El Nino to strengthen further, peak around December and continue through February 2027.”

Reservoir levels about 71% of capacity, at least 25% lower than last year

Suresh Ramachandran · Managing Director · p. 5
“Current estimates mention that reservoir levels across the country are at about 71% of the capacity and at least 25% lower than the last year at the same time.”

Exports: Q2 export setback due to overstocking of products exported to the parent

Suresh Ramachandran · Managing Director · Q&A · p. 11
“The major setback or the major challenge happened in the quarter 2 primarily due to overstocking of some of the products to export to our parent company.”

Sales returns not expected to affect H2

Suresh Ramachandran · Managing Director · Q&A · p. 12
“We don't expect the sales return to be impacting our second half.”

No significant adverse factors expected in revenue or margins

Kunal Mittal · Executive Vice President · Q&A · p. 17
“We are not expecting significant any adverse factors in either revenues or any kind of margin, which you refer to.”

Other

New management says strategy and financial discipline remain unchanged

Suresh Ramachandran · Managing Director · p. 3
“Our commitment to you is continuity. The strategy, the financial discipline and the farmer-first approach that delivered our results over the last several years remain unchanged.”

Q2 FY27 revenue was Rs 907 crore, down 2% year-on-year

Kunal Mittal · Executive Vice President · p. 7
“Q2 financial year '27, the revenue was INR907 crores, down 2% year-on-year.”

H1 FY27 revenue was Rs 1,971 crore, down 1%

Kunal Mittal · Executive Vice President · p. 7
“HI financial year '27 revenue was INR1,971 crores, down 1% as compared to previous year.”

Q2 operating EBITDA Rs 187 crore, down 15%

Anil Nawal · Chief Financial Officer · p. 9
“Operating EBITDA was INR187 crores down 15% with an EBITDA margin of 20.5%, down 297 basis points.”

Q2 net profit Rs 157 crore vs Rs 178 crore, down 11%

Anil Nawal · Chief Financial Officer · p. 9
“The net profit was INR157 crores compared with INR178 crores last year, down 11% with a net profit margin of 17.3%.”

Sources

Management's own statements, quoted from its NSE filings. This page was read by AI and can contain mistakes: check the source pages before relying on any figure. No forecast or opinion of ours. Not investment advice.

Search

Search funds, ETFs, stocks, pages and tools